Sort
30,917 grants matching “tumor microenvironment”
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
$423,186Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
$423,186Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
$423,130Asmaa Elkenawi · Indiana University Indianapolis · R21 · FY2023 · CA
Impact of aging and clonal hematopoiesis on epigenetic heterogeneity, evolvability, and leukemogenesis
$423,109Sheng Li · Jackson Laboratory · U01 · FY2021 · CA
Anti-Tumor Mechanisms of Intratumoral Stimulatory Dendritic Cells
$423,092Matthew F Krummel · University Of California, San Francisco · R01 · FY2019 · CA
Mechanisms of Immune-mediated Tumor Cell Destruction
$423,078Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Defining therapeutic strategies for boosting T-cell infiltration into cold tumors with spatial proteomics and machine learning
$423,078Matthew W. Thomson · California Institute Of Technology · R21 · FY2023 · CA
Exploiting the immunomodulatory effects of sulindac and novel non-COX inhibitory derivatives for cancer treatment
$423,057Gang Zhou · Augusta University · R01 · FY2022 · CA
Exploiting the immunomodulatory effects of sulindac and novel non-COX inhibitory derivatives for cancer treatment
$423,057Gang Zhou · Augusta University · R01 · FY2023 · CA
Project 2: Immune signals promoting pancreas cancer stemness and progression
$423,030Steven E Artandi · Stanford University · P01 · FY2025 · CA
Exosomes in tumor cell-mesenchymal stromal cell interaction
$423,016Yves A Declerck · Children'S Hospital Of Los Angeles · R01 · FY2017 · CA
Three-dimensional organoid models to study breast cancer progression
$423,004Shilpa Sant · University Of Illinois At Chicago · R37 · FY2023 · CA
Unraveling Vascular Mediated Immune Exclusion in Melanoma
$422,971Minah Kim · Columbia University Health Sciences · R21 · FY2024 · CA
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy
$422,964Zhiguo Li · University Of Kentucky · R01 · FY2024 · CA
Advancing CAR T cell therapy for solid tumors
$422,916Jalal Ahmed · Icahn School Of Medicine At Mount Sinai · DP5 · FY2021 · OD
Project 3 â Stromal derived IL-6/STAT3 signaling in the development and progression of PDAC
$422,885Michael C Ostrowski · Medical University Of South Carolina · P01 · FY2025 · CA
Frontiers in Bone Metastatic Models for Prostate Cancer
$422,874Leslie Ann Caromile · University Of Connecticut Sch Of Med/Dnt · R21 · FY2024 · CA
Targeted Radiation Therapy for Pancreatic Cancer
$422,866Surinder Kumar Batra · University Of Nebraska Medical Center · R01 · FY2019 · CA
Optimizing Targeted Breast Cancer Therapy by Mathematical Modeling and Experimental Studies
$422,819William Thomas Baumann · Virginia Polytechnic Inst And St Univ · R01 · FY2016 · CA
The role of the tumor biofilm in determining tissue tropism
$422,809Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Integrating cancer genomics and spatial architecture of tumor infiltrating lymphocytes
$422,790Hanlee Ji · Stanford University · R01 · FY2024 · CA
A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer
$422,658Ashutosh Agarwal · University Of Miami School Of Medicine · U01 · FY2020 · CA
METEOR-BioLogical Specimen Translation (METEOR-BLST)
$422,630Michael Benjamin Major · Washington University · U54 · FY2023 · CA
Transport Oncophysics Core
$422,589Haifa Shen · Methodist Hospital Research Institute · U54 · FY2020 · CA
Advancing CAR T cell therapy for solid tumors
$422,500Jalal Ahmed · Icahn School Of Medicine At Mount Sinai · DP5 · FY2023 · OD